Objectives: To assess efficacy and safety of rituximab (RTX) induction and maintenance therapy for granulomatosiswith polyangiitis (GPA) in a single-centre cohort study
Introduction Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cyto...
Abstract Granulomatosis with polyangiitis and micro-scopic polyangiitis are anti-neutrophil cytoplas...
The present report illustrates efficacy of rituximab (RTX) in granulomatosis with polyangiitis (GPA)...
Univ Paris 05, Hop Cochin, AP HP, Natl Referral Ctr Rare System Autoimmune Dis, Paris, FranceUniv Fe...
Rituximab (RTX) is an anti-CD20 antibody used successfully in granulomatosis with polyangiitis (GPA)...
Objective:Recent guidelines recommend rituximab for maintenance therapy in severe ANCA-associated va...
Shivani Shah, Duvuru Geetha Department of Medicine, Division of Nephrology, Johns Hopkins University...
Findings of several reports suggest that rituximab, a chimeric monoclonal anti-CD20 antibody causing...
and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case...
Granulomatosis with polyangiitis and microscopic polyangiitis are anti-neutrophil cytoplasmic antibo...
Sponsorships or competing interests that may be relevant to content are dis-closed at the end of thi...
Objective: Recently few reports have suggested a potential benefit of rituximab in patients with eos...
Granulomatosis with polyangiitis and microscopic polyangiitis are anti-neutrophil cytoplasmic antibo...
Objective. Rituximab (RTX) therapy is a treatment option in patients with refractory antineutrophil ...
Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis wi...
Introduction Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cyto...
Abstract Granulomatosis with polyangiitis and micro-scopic polyangiitis are anti-neutrophil cytoplas...
The present report illustrates efficacy of rituximab (RTX) in granulomatosis with polyangiitis (GPA)...
Univ Paris 05, Hop Cochin, AP HP, Natl Referral Ctr Rare System Autoimmune Dis, Paris, FranceUniv Fe...
Rituximab (RTX) is an anti-CD20 antibody used successfully in granulomatosis with polyangiitis (GPA)...
Objective:Recent guidelines recommend rituximab for maintenance therapy in severe ANCA-associated va...
Shivani Shah, Duvuru Geetha Department of Medicine, Division of Nephrology, Johns Hopkins University...
Findings of several reports suggest that rituximab, a chimeric monoclonal anti-CD20 antibody causing...
and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case...
Granulomatosis with polyangiitis and microscopic polyangiitis are anti-neutrophil cytoplasmic antibo...
Sponsorships or competing interests that may be relevant to content are dis-closed at the end of thi...
Objective: Recently few reports have suggested a potential benefit of rituximab in patients with eos...
Granulomatosis with polyangiitis and microscopic polyangiitis are anti-neutrophil cytoplasmic antibo...
Objective. Rituximab (RTX) therapy is a treatment option in patients with refractory antineutrophil ...
Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis wi...
Introduction Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cyto...
Abstract Granulomatosis with polyangiitis and micro-scopic polyangiitis are anti-neutrophil cytoplas...
The present report illustrates efficacy of rituximab (RTX) in granulomatosis with polyangiitis (GPA)...
DOI
Add to ORKG